Manufacturing channel feed – Endpoints News

The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

2 months ago

FDA says Ozempic, Wegovy shortage is over

2 months ago

Charles River’s $1B revenue; Theratechnologies restarts HIV drug supply

2 months ago

Drug packaging manufacturers brace for impact as EU chemical ban looms

2 months ago

Bare footprints and blocked inspectors: FDA places two Indian manufacturers on import alerts

2 months ago

Pfizer’s manufacturing arm at risk from Trump tariffs in Europe, Bourla says

2 months ago

Siegfried’s stock slips over dampened sales outlook for 2025

2 months ago

West Pharma loses two glucose device clients but is buoyed by its GLP-1 packaging services

2 months ago

Updated: Moderna reports $238M manufacturing write-down as cuts, new vaccines shape 2025

2 months ago

Syngene CEO departs; Lilly and AdvanCell sign radiotherapy partnership

2 months ago

FDA puts two Chinese API makers on import alert after failed inspections

2 months ago

Trump’s tariff impact likely ‘minimal’ for brand-name drugmakers, manufacturing partners

2 months ago

Belgian regulator recommends blocking Indian drugmaker's API production

3 months ago

AstraZeneca cuts UK funding pledge; Viking says it has ‘enough’ API for trials

3 months ago

Updated: Novo Nordisk sees growth slowing this year, plans CagriSema filing for 2026

3 months ago

Bavarian Nordic’s stock sinks after 2024 revenues underwhelm

3 months ago

Charles River to shut down North Carolina pathology facility, says it's not a 'strategic fit'

3 months ago

Thermo Fisher to lay off 300 workers at two viral vector factories

3 months ago

Updated: Drug prices likely to soar due to Trump tariffs, pharma bodies warn

3 months ago

J&J’s Rybrevant gets CHMP backing weeks after FDA rejection

3 months ago

AstraZeneca scraps UK vaccine site expansion after government budget cuts

3 months ago

Celltrion looks to buy US facilities to sidestep potential Trump tariffs

3 months ago

Rentschler exits cell and gene business due to low demand, will prioritize biologics

3 months ago

Bright Green budgets $3.5B for new builds; European Commission opens biomanufacturing hub

3 months ago

First page Previous page 1 2 345 6 7 Next page Last page